Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease
about
Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database.Calcitriol Suppression of Parathyroid Hormone Fails to Improve Skeletal Properties in an Animal Model of Chronic Kidney Disease.Effects of combination treatment with alendronate and raloxifene on skeletal properties in a beagle dog model.Raloxifene Improves Bone Mechanical Properties in Mice Previously Treated with Zoledronate.Effects of raloxifene and alendronate on non-enzymatic collagen cross-links and bone strength in ovariectomized rabbits in sequential treatments after daily human parathyroid hormone (1-34) administration.
P2860
Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Raloxifene improves skeletal p ...... cystic chronic kidney disease
@en
type
label
Raloxifene improves skeletal p ...... cystic chronic kidney disease
@en
prefLabel
Raloxifene improves skeletal p ...... cystic chronic kidney disease
@en
P2093
P2860
P356
P1433
P1476
Raloxifene improves skeletal p ...... cystic chronic kidney disease
@en
P2093
Amy Creecy
Christopher L Newman
Drew M Brown
Jeffry S Nyman
Mathilde Granke
Matthew R Allen
Max A Hammond
Nannan Tian
Sharon M Moe
P2860
P2888
P304
P356
10.1038/KI.2015.315
P407
P577
2015-10-21T00:00:00Z
P6179
1050187289